Studies have confirmed that baicalein suppresses the activation of AKT/mTOR pathway by inhibiting the expression of caveolin-1 protein, thereby reducing the proliferation and metastasis of prostate cancer cells (Guo et al., 2015). The gene discussed is AKT1; the disease is prostate cancer.